Titre:
  • Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): Subgroup analysis from the AMBITION trial
Auteur:Coghlan, John Gerry; Simonneau, Gerald; Vachiery, Jean-Luc; Blair, Christiana; Gillies, Hunter; Miller, Karen K.L.; Harris, Julia H N; Langley, Jonathan; Rubin, Lewis; Galie, Nazzareno; Barberà, Joan Albert; Frost, Adaani; Ghofrani, Hossein Ardeschir; Hoeper, Marius M.; Kuwana, Masataka; McLaughlin, Vallerie; Peacock, Andrew J.
Informations sur la publication:Annals of the Rheumatic Diseases, 76, 7, page (1219-1227)
Statut de publication:Publié, 2017-07
Sujet CREF:Allergie et immunopathologie
Rhumatologie
Immunologie
Biologie
Mots-clés:Arterial Hypertension
Systemic Sclerosis
Treatment
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0003-4967
info:doi/10.1136/annrheumdis-2016-210236
info:scp/85010425197